In this episode of Arthritis At Home, Ellen Wang, Programs Coordinator at Arthritis Consumer Experts, has a discussion with Dr. Carrie Ye, an Associate Professor from the University of Alberta, about rheum-oncology and artificial intelligence in rheumatology.
Carrie shared how her interests developed at the intersection of patient care, epidemiology, and complex systemic disease, particularly in the context of cancer immunotherapies and their rheumatic and bone-related toxicities. The conversation explored rheum-oncology as an emerging discipline, highlighting the importance of collaboration between rheumatologists and oncologists, as well as her leadership with Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO) in building national capacity and shared learning in this space. The episode concludes with a thoughtful discussion on the biggest opportunities for artificial intelligence in rheumatology, such as earlier detection and more personalized care, alongside key challenges including accuracy, bias, and environmental impact.
About Dr. Carrie Ye
Carrie is an Associate Professor, Department of Medicine, at the University of Alberta, and a research scientist at Arthritis Research Canada. Her rheumatology practice is focused on osteoporosis and rheumatic toxicities of cancer immunotherapy. She is also the Medical Director of the Northern Alberta Osteoporosis Program and the Clinical Lead of the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO). More recently, her research has explored the use of large health datasets and artificial intelligence to improve the identification and management of rheumatic and bone health conditions.
Additional learning resources